This inventor holds 2 USPTO granted patents. Top assignee: Transpharma Medical Ltd.. Active years: 2009-2011.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2009-2011
Title: Amikam Gershonowitz: Innovator in Transdermal Delivery Systems
Introduction
Amikam Gershonowitz is a notable inventor based in Modiin, Israel. He has made significant contributions to the field of transdermal delivery systems, holding a total of 2 patents. His work focuses on innovative methods for delivering pharmaceutical agents through the skin, which has important implications for immunization and gene therapy.
Latest Patents
Gershonowitz's latest patents include a transdermal delivery system for polynucleotides. This system employs an apparatus that generates micro-channels in the skin, allowing for the effective delivery of oligonucleotides or polynucleotides. The method is designed to achieve expression of target proteins encoded by the polynucleotides, making it useful in both immunization and gene therapy. Another significant patent involves combined micro-channel generation and iontophoresis for transdermal delivery of pharmaceutical agents. This method enhances the transdermal delivery process by generating micro-channels on the skin and delivering pharmaceutical agents iontophoretically.
Career Highlights
Amikam Gershonowitz is associated with Transpharma Medical Ltd., where he continues to develop and refine his innovative technologies. His work has positioned him as a key figure in the advancement of transdermal delivery systems.
Collaborations
Gershonowitz collaborates with talented individuals such as Galit Levin and Meir Stern, contributing to a dynamic research environment that fosters innovation.
Conclusion
Amikam Gershonowitz's contributions to transdermal delivery systems highlight his role as a leading inventor in the field. His patents reflect a commitment to advancing medical technology and improving therapeutic delivery methods.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile